Crossmark

Quality assessment and Q-markers discovery of Tongsaimai tablet by integrating serum pharmacochemistry and network pharmacology for anti-atherosclerosis benefit

Crossref DOI link: https://doi.org/10.1186/s13020-022-00658-9

Published Online: 2022-09-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cheng, Yanfen

Xiao, Meng

Chen, Jiamei

Wang, Di

Hu, Yichen

Zhang, Chenfeng

Wang, Tuanjie

Fu, Chaomei

Wu, Yihan

Zhang, Jinming
Funding

Funding for this research was provided by:

State Key Laboratory of Synthetical Automation for Process Industries (SKL2020Z0303)

Sichuan Province Science and Technology Support Program (2021083)
License Information

Text and Data Mining valid from 2022-09-02

Version of Record valid from 2022-09-02
More Information

Article History

Received: 12 May 2022

Accepted: 22 August 2022

First Online: 2 September 2022

Declarations

:

: The animal experiments were approved by the ethics committee of the Chengdu University of Traditional Chinese Medicine (CDUTCM, permit CDU2020KB097), and were conducted in strict accordance with the Guidelines for the Use Committee 520 (IACUC) of Chengdu University of Traditional Chinese Medicine.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below